In conclusion, despite the fact TGF-β-oriented treatments regarding thyroid autoimmunity are still at an experimental level, targeting the dual immune role of TGF-β (inhibitory or enhancing) could lead to the development of innovative therapies for autoimmune thyroid diseases (Table 3). The gene discussed is TGFB1; the disease is autoimmune thyroid disease.